진정 최면제 시장 보고서(2026년)

A sedative-hypnotic drug is a chemical substance used to reduce tension and anxiety, induce a feeling of calm (sedative effect), or assist in initiating sleep (hypnotic effect). These drugs work by suppressing the limbic system of the brain, which controls emotional and behavioral responses, as well as the reticular formation, which regulates sleep patterns and overall consciousness.

The primary categories of sedative-hypnotic drugs include benzodiazepines, barbiturates, antihistamines, nonbenzodiazepines, and others. Benzodiazepines are a class of medications that reduce activity in the brain and nervous system and are used to relieve symptoms of anxiety and insomnia due to their calming effects on the central nervous system. They can be administered via multiple routes, including oral, parenteral, and others, to treat various conditions such as sleep disorders, anesthesia, pain, and more. These medications are distributed through different channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others, to a range of end-users, including hospitals, specialty clinics, home care, and beyond.

Tariffs have impacted the sedative-hypnotic drugs market by increasing costs associated with imported active pharmaceutical ingredients and formulation excipients, particularly affecting benzodiazepines and nonbenzodiazepine segments. These effects are more pronounced in regions reliant on international pharmaceutical supply chains, including parts of Asia-Pacific and Latin America. Higher tariffs can lead to elevated drug prices and supply delays in hospital and retail pharmacies. Conversely, tariffs have encouraged local manufacturing and generic drug production, improving supply security and reducing long-term dependence on imports.

The sedative-hypnotic drugs market research report is one of a series of new reports from The Business Research Company that provides sedative-hypnotic drugs market statistics, including sedative-hypnotic drugs industry global market size, regional shares, competitors with a sedative-hypnotic drugs market share, detailed sedative-hypnotic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the sedative-hypnotic drugs industry. This sedative-hypnotic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sedative-hypnotic drugs market size has grown strongly in recent years. It will grow from $3.86 billion in 2025 to $4.18 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to high prevalence of sleep disorders, widespread use of benzodiazepines in anxiety treatment, increased surgical procedures requiring anesthesia, rising stress-related disorders, availability of low-cost generic sedatives.

The sedative-hypnotic drugs market size is expected to see strong growth in the next few years. It will grow to $5.51 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to growing incidence of insomnia and sleep disorders, increasing aging population, rising demand for safer long-term sleep medications, expansion of nonbenzodiazepine drug classes, greater awareness of mental health conditions. Major trends in the forecast period include growing shift toward nonbenzodiazepine sleep aids, rising preference for short-acting sedative formulations, increasing focus on reduced dependency and abuse potential, expansion of home-based sleep disorder management, greater emphasis on safety profiles in chronic use.

The increasing stress levels are anticipated to drive the expansion of the sedative-hypnotic drugs market in the coming years. Stress is defined as the emotional or mental strain caused by demanding or unpredictable situations, including economic difficulties, workplace pressures, political instability, and wider social or psychological challenges. The rise in stress levels can be attributed to factors such as financial uncertainty, heightened job demands, and prolonged societal disruptions, which together have led to increased emotional strain among adults. Sedative-hypnotic drugs aid mental well-being by alleviating anxiety, promoting relaxation, and enhancing sleep quality, thereby addressing the growing stress burden faced by individuals. For example, in May 2024, the American Psychiatric Association, a U.S.-based organization, reported that 43% of U.S. adults felt more anxious than they had the previous year, up from 37% in 2023 and 32% in 2022, highlighting an upward trend in anxiety levels. Consequently, the rising stress levels are contributing to the growth of the sedative-hypnotic drugs market.

The growing geriatric population is anticipated to drive the expansion of the sedative-hypnotic drugs market in the coming years. The geriatric population refers to individuals typically aged 65 years and older, encompassing older adults who may have distinct healthcare, social, and physiological needs associated with aging. The rise in the geriatric population is mainly due to increased life expectancy, which allows more people to live longer because of improved healthcare, better disease management, and enhanced living conditions. Sedative-hypnotic drugs support the geriatric population by enhancing sleep quality, reducing nighttime agitation, and promoting overall cognitive and physical well-being in older adults. For example, in July 2024, according to the UK Parliament's House of Commons Library, in 2022, there were 12.7 million people aged 65 or older in the UK, representing 19% of the total population. This number is expected to increase to 22.1 million by 2072, accounting for 27% of the population. Therefore, the growing geriatric population is contributing to the expansion of the sedative-hypnotic drugs market.

Major companies in the sedative-hypnotic drugs market are concentrating on developing innovative approaches such as next-generation insomnia therapies to enhance sleep quality and safety. Next-generation insomnia therapies are advanced treatments aimed at improving sleep quality and safety by targeting specific sleep mechanisms while minimizing side effects compared to traditional sedative-hypnotics. For example, in June 2025, Simcere Pharmaceutical Group Limited, a China-based biopharmaceutical company, collaborated with Idorsia Ltd., a Switzerland-based biopharmaceutical company, to introduce QUVIVIQ (Daridorexant Hydrochloride Tablets), an anti-insomnia medication, to the Chinese market. The drug was later approved by the National Medical Products Administration (NMPA) for treating adult patients with insomnia characterized by difficulty falling asleep and maintaining sleep. Importantly, QUVIVIQ is not classified as a psychotropic drug, providing a treatment option without the regulatory restrictions commonly associated with sedative-hypnotic medications.

Major companies operating in the sedative-hypnotic drugs market are Pfizer Inc., Sun Pharmaceutical Industries Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi-Aventis AG, AstraZeneca Plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Eli Lilly and Co., Teva Pharmaceutical Industries Ltd., Mylan N.V., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Glenmark Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Abbott Laboratories

North America was the largest region in the sedative-hypnotic drugs market in 2025. The regions covered in the sedative-hypnotic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sedative-hypnotic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sedative-hypnotic drugs market consists of sales of tablets, capsules, injectables, and liquid formulations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sedative-Hypnotic Drugs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses sedative-hypnotic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sedative-hypnotic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sedative-hypnotic drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Drug Class: Benzodiazepines; Barbiturates; Antihistamines; Nonbenzodiazepine; Other Drug Classes
• 2) By Route of Administration: Oral; Parenteral; Other Routes of Administration
• 3) By Disease Type: Sleep Disorders; Anesthesia; Pain; Other Disease Types
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
• 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
• Subsegments:
• 1) By Benzodiazepines: Diazepam; Lorazepam; Alprazolam
• 2) By Barbiturates: Phenobarbital; Thiopental; Pentobarbital
• 3) By Antihistamines: Diphenhydramine; Hydroxyzine
• 4) By Nonbenzodiazepine: Zolpidem; Eszopiclone; Zaleplon
• 5) By Other Drug Classes: Melatonin Receptor Agonists; Orexin Receptor Antagonists
• Companies Mentioned: Pfizer Inc.; Sun Pharmaceutical Industries Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Sanofi-Aventis AG; AstraZeneca Plc; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Boehringer Ingelheim International GmbH; Eli Lilly and Co.; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Aurobindo Pharma Limited; Cipla Inc.; Dr. Reddy's Laboratories Ltd.; Hikma Pharmaceuticals plc; Lupin Pharmaceuticals Inc.; Glenmark Pharmaceuticals Inc.; Torrent Pharmaceuticals Ltd.; Abbott Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Sedative-Hypnotic Drugs Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Sedative-Hypnotic Drugs Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Sedative-Hypnotic Drugs Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Sedative-Hypnotic Drugs Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Growing Shift Toward Nonbenzodiazepine Sleep Aids
  • 4.2.2 Rising Preference For Short-Acting Sedative Formulations
  • 4.2.3 Increasing Focus On Reduced Dependency And Abuse Potential
  • 4.2.4 Expansion Of Home-Based Sleep Disorder Management
  • 4.2.5 Greater Emphasis On Safety Profiles In Chronic Use

5. Sedative-Hypnotic Drugs Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Specialty Clinics
• 5.3 Homecare Settings
• 5.4 Sleep Disorder Centers
• 5.5 Ambulatory Surgical Centers

6. Sedative-Hypnotic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Sedative-Hypnotic Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Sedative-Hypnotic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Sedative-Hypnotic Drugs Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Sedative-Hypnotic Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Sedative-Hypnotic Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Sedative-Hypnotic Drugs Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Sedative-Hypnotic Drugs Market Segmentation

• 9.1. Global Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Benzodiazepines, Barbiturates, Antihistamines, Nonbenzodiazepine, Other Drug Classes
• 9.2. Global Sedative-Hypnotic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral, Parenteral, Other Routes of Administration
• 9.3. Global Sedative-Hypnotic Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sleep Disorders, Anesthesia, Pain, Other Disease Types
• 9.4. Global Sedative-Hypnotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
• 9.5. Global Sedative-Hypnotic Drugs Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Specialty Clinics, Homecare, Other End-Users
• 9.6. Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Benzodiazepines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diazepam, Lorazepam, Alprazolam
• 9.7. Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Barbiturates, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Phenobarbital, Thiopental, Pentobarbital
• 9.8. Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diphenhydramine, Hydroxyzine
• 9.9. Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Nonbenzodiazepine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Zolpidem, Eszopiclone, Zaleplon
• 9.10. Global Sedative-Hypnotic Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Melatonin Receptor Agonists, Orexin Receptor Antagonists

10. Sedative-Hypnotic Drugs Market Regional And Country Analysis

• 10.1. Global Sedative-Hypnotic Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Sedative-Hypnotic Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Sedative-Hypnotic Drugs Market

• 11.1. Asia-Pacific Sedative-Hypnotic Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Sedative-Hypnotic Drugs Market

• 12.1. China Sedative-Hypnotic Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Sedative-Hypnotic Drugs Market

• 13.1. India Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Sedative-Hypnotic Drugs Market

• 14.1. Japan Sedative-Hypnotic Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Sedative-Hypnotic Drugs Market

• 15.1. Australia Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Sedative-Hypnotic Drugs Market

• 16.1. Indonesia Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Sedative-Hypnotic Drugs Market

• 17.1. South Korea Sedative-Hypnotic Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Sedative-Hypnotic Drugs Market

• 18.1. Taiwan Sedative-Hypnotic Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Sedative-Hypnotic Drugs Market

• 19.1. South East Asia Sedative-Hypnotic Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Sedative-Hypnotic Drugs Market

• 20.1. Western Europe Sedative-Hypnotic Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Sedative-Hypnotic Drugs Market

• 21.1. UK Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Sedative-Hypnotic Drugs Market

• 22.1. Germany Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Sedative-Hypnotic Drugs Market

• 23.1. France Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Sedative-Hypnotic Drugs Market

• 24.1. Italy Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Sedative-Hypnotic Drugs Market

• 25.1. Spain Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Sedative-Hypnotic Drugs Market

• 26.1. Eastern Europe Sedative-Hypnotic Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Sedative-Hypnotic Drugs Market

• 27.1. Russia Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Sedative-Hypnotic Drugs Market

• 28.1. North America Sedative-Hypnotic Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Sedative-Hypnotic Drugs Market

• 29.1. USA Sedative-Hypnotic Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Sedative-Hypnotic Drugs Market

• 30.1. Canada Sedative-Hypnotic Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Sedative-Hypnotic Drugs Market

• 31.1. South America Sedative-Hypnotic Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Sedative-Hypnotic Drugs Market

• 32.1. Brazil Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Sedative-Hypnotic Drugs Market

• 33.1. Middle East Sedative-Hypnotic Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Sedative-Hypnotic Drugs Market

• 34.1. Africa Sedative-Hypnotic Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Sedative-Hypnotic Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Sedative-Hypnotic Drugs Market Regulatory and Investment Landscape

36. Sedative-Hypnotic Drugs Market Competitive Landscape And Company Profiles

• 36.1. Sedative-Hypnotic Drugs Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Sedative-Hypnotic Drugs Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Sedative-Hypnotic Drugs Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Sun Pharmaceutical Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Sanofi-Aventis AG Overview, Products and Services, Strategy and Financial Analysis

37. Sedative-Hypnotic Drugs Market Other Major And Innovative Companies

• AstraZeneca Plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Eli Lilly and Co., Teva Pharmaceutical Industries Ltd., Mylan N.V., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Glenmark Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Abbott Laboratories

38. Global Sedative-Hypnotic Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Sedative-Hypnotic Drugs Market

40. Sedative-Hypnotic Drugs Market High Potential Countries, Segments and Strategies

• 40.1 Sedative-Hypnotic Drugs Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Sedative-Hypnotic Drugs Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Sedative-Hypnotic Drugs Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer